https://www.acplgroupindia.in
91

What are the requirements for import of Class-A/B/C/D In Vitro Diagnostic Medical device ...

View more

POLICY ON NEW DRUG APPLICATION: 1. The content of New Drug Application (NDA) should be des...

View more

Design and development validation: Design and development validation shall be performed in...

View more

ND & CT rules recognize the consideration of surrogate endpoints for approval of new drugs...

View more

POLICY ON NEW DRUG APPLICATION: 1. The content of New Drug Application (NDA) should be des...

View more

ND & CT rules recognize the consideration of surrogate endpoints for approval of new drugs...

View more

POLICY ON NEW DRUG APPLICATION: 1. The content of New Drug Application (NDA) should be des...

View more

Our business is based on high standards, trust, and personalized attention to all projects...

View more

10.As provided in the rules, surrogate marker should be considered as an interim data poin...

View more

Subscribe for latest offers and updates.

we hate spam too